Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development Program

Go back to Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development Program
CODEXIS (NASDAQ: CDXS) Delayed: 2.39 +0.02 (0.84%)
Previous Close $2.37    52 Week High $5.25 
Open $2.33    52 Week Low $2.93 
Day High $2.44    P/E N/A 
Day Low $2.32    EPS $-1.25 
Volume 396,288